Statistics from Altmetric.com
e-Cigarettes: a double-edged sword?
The use of e-cigarettes has rapidly increased. A UK based randomised trial by Hajek et al (NEJM 2019;380:629) evaluated the effectiveness of e-cigarettes versus nicotine replacement therapy (NRT) as a tool for smoking cessation. Adults attending National Health Service smoking cessation services not currently using NRT or e-cigarettes were eligible. Participants had to agree to not use the non-assigned treatment for at least 4 weeks post quit date. 886 adults already attending stop smoking services were randomised to receive either refillable e-cigarettes (439/886) or a range of NRT (447/886) of their choice. Behavioural support was offered to both groups. NRT was offered for 12 months (~£120 for 3-month supply) or a starter e-cigarette pack with one liquid refill (~£30.25) and encouragement to purchase additional refills themselves. Sustained abstinence was defined as no more than five cigarettes 2 weeks following the quit date and exhaled CO <8 ppm at 52 weeks. Those in the e-cigarette group were statistically more likely to achieve abstinence at each timepoint analysed (4 weeks, 26 weeks and 26–52 weeks) including the primary outcome at 1 year (18.0% vs 9.9%, relative risk (RR) 1.83; 95% CI 1.30 to 2.58). The side effect profile was also investigated. Participants in the NRT arm were more likely to suffer from nausea (37.9% vs 31.3%) and ongoing cough with …
Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.
Competing interests None declared.
Patient consent for publication Not required.
Provenance and peer review Not commissioned; internally peer reviewed.
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.